DSC Advisors, L.P. - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 46 filers reported holding VYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DSC Advisors, L.P. ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$235,500
-60.5%
1,570,000
-41.2%
0.54%
-11.9%
Q3 2022$596,000
-42.6%
2,670,0000.0%0.61%
-40.8%
Q2 2022$1,038,000
-40.2%
2,670,0000.0%1.04%
+73.4%
Q1 2022$1,736,000
-33.3%
2,670,000
+4.7%
0.60%
-70.2%
Q4 2021$2,602,000
+70.2%
2,551,000
+131.9%
2.01%
+29.4%
Q3 2021$1,529,000
-60.4%
1,100,0000.0%1.55%
-44.3%
Q2 2021$3,861,000
-45.7%
1,100,000
+6.0%
2.79%
-36.6%
Q1 2021$7,106,0001,038,1454.40%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders